Your browser doesn't support javascript.
loading
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis.
Filippi, Roberto; Leone, Francesco; Fornaro, Lorenzo; Aprile, Giuseppe; Casadei-Gardini, Andrea; Silvestris, Nicola; Palloni, Andrea; Satolli, Maria Antonietta; Scartozzi, Mario; Russano, Marco; Lutrino, Stefania Eufemia; Lombardi, Pasquale; Frega, Giorgio; Garattini, Silvio Ken; Vivaldi, Caterina; Spadi, Rosella; Giulia, Orsi; Fenocchio, Elisabetta; Brunetti, Oronzo; Aglietta, Massimo; Brandi, Giovanni.
Afiliación
  • Filippi R; Department of Oncology, University of Turin, Torino, Italy.
  • Leone F; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Fornaro L; Division of Medical Oncology 1, Centro Oncologico Ematologico Subalpino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
  • Aprile G; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, Italy.
  • Casadei-Gardini A; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Silvestris N; Department of Oncology, University Hospital of Udine, Udine, Italy.
  • Palloni A; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.
  • Satolli MA; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.
  • Scartozzi M; Department of Oncology and Haematology, University Hospital of Modena, Italy.
  • Russano M; Medical Oncology Unit, IRCCS Cancer Institute "Giovanni Paolo II", Bari, Italy.
  • Lutrino SE; Department of Experimental, Diagnostic and Speciality Medicine, University Hospital S. Orsola-Malpighi, Bologna, Italy.
  • Lombardi P; Department of Oncology, University of Turin, Torino, Italy.
  • Frega G; Division of Medical Oncology 1, Centro Oncologico Ematologico Subalpino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
  • Garattini SK; Department of Medical Oncology, University Hospital, Cagliari, Italy.
  • Vivaldi C; Department of Medical Oncology, Campus Bio-Medico University, Roma, Italy.
  • Spadi R; Department of Oncology, Ospedale Vito Fazzi, Lecce, Italy.
  • Giulia O; Department of Oncology, University of Turin, Torino, Italy.
  • Fenocchio E; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Brunetti O; Department of Experimental, Diagnostic and Speciality Medicine, University Hospital S. Orsola-Malpighi, Bologna, Italy.
  • Aglietta M; Department of Oncology, University Hospital of Udine, Udine, Italy.
  • Brandi G; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
J Chemother ; 34(2): 123-132, 2022 Apr.
Article en En | MEDLINE | ID: mdl-34313188

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Sistema Biliar Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Chemother Asunto de la revista: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Sistema Biliar Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Chemother Asunto de la revista: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Italia